153 related articles for article (PubMed ID: 27306686)
21. [Primary laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ-cell testis tumor].
Castillo OA; Sánchez-Salas R; Secin FP; Campero JM; Foneron A; Vidal-Mora I
Actas Urol Esp; 2011 Jan; 35(1):22-8. PubMed ID: 21256391
[TBL] [Abstract][Full Text] [Related]
22. Is modified retroperitoneal lymph node dissection alive for clinical stage I non-seminomatous germ cell testicular tumor?
Basiri A; Ghaed MA; Simforoosh N; Tabibi A; Danesh A; Nouralizadeh A; Parizi MK
Urol J; 2013; 10(2):873-7. PubMed ID: 23801470
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive systematic review of testicular germ cell tumor surveillance.
Groll RJ; Warde P; Jewett MA
Crit Rev Oncol Hematol; 2007 Dec; 64(3):182-97. PubMed ID: 17644403
[TBL] [Abstract][Full Text] [Related]
24. Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysis.
Nguyen CT; Fu AZ; Gilligan TD; Wells BJ; Klein EA; Kattan MW; Stephenson AJ
J Clin Oncol; 2010 Jan; 28(1):119-25. PubMed ID: 19917846
[TBL] [Abstract][Full Text] [Related]
25. Survival outcomes of adolescent and adult patients with non-seminomatous testicular germ-cell tumors: A population-based study.
Amini A; Waxweiler TV; Maroni PD; Kessler ER; Cost CR; Greffe BS; Garrington TP; Liu AK; Cost NG
J Pediatr Urol; 2016 Dec; 12(6):405.e1-405.e9. PubMed ID: 27544905
[TBL] [Abstract][Full Text] [Related]
26. Active surveillance for stage I non-seminomatous germ cell testis tumors: practice and pitfalls.
Raghavan D; Boyer M
Prog Clin Biol Res; 1990; 350():309-18. PubMed ID: 2166960
[No Abstract] [Full Text] [Related]
27. Lactate dehydrogenase as a marker for testicular germ-cell tumours.
Taylor RE; Duncan W; Horn DB
Eur J Cancer Clin Oncol; 1986 Jun; 22(6):647-53. PubMed ID: 3017721
[TBL] [Abstract][Full Text] [Related]
28. Surgical management of low-stage nonseminomatous germ cell testicular cancer.
Stephenson AJ; Klein EA
BJU Int; 2009 Nov; 104(9 Pt B):1362-8. PubMed ID: 19840014
[TBL] [Abstract][Full Text] [Related]
29. Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.
Sun M; Abdollah F; Budaüs L; Liberman D; Tian Z; Morgan M; Johal R; Schmitges J; Shariat SF; Montorsi F; Greafen M; Perrotte P; Karakiewicz PI
Ann Surg Oncol; 2011 Oct; 18(10):2997-3004. PubMed ID: 21509630
[TBL] [Abstract][Full Text] [Related]
30. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
Haugnes HS; Laurell A; Stierner U; Bremnes RM; Dahl O; Cavallin-Ståhl E; Cohn-Cedermark G
Acta Oncol; 2012 Feb; 51(2):168-76. PubMed ID: 22175254
[TBL] [Abstract][Full Text] [Related]
31. Compliance of males with stage 1 testicular germ cell tumours on an active surveillance protocol.
Honeyball F; Murali-Ganesh R; Hruby G; Grimison P
Intern Med J; 2015 Oct; 45(10):1081-4. PubMed ID: 26429219
[TBL] [Abstract][Full Text] [Related]
32. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
33. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
Stephenson AJ; Bosl GJ; Motzer RJ; Bajorin DF; Stasi JP; Sheinfeld J
J Clin Oncol; 2007 Dec; 25(35):5597-602. PubMed ID: 18065732
[TBL] [Abstract][Full Text] [Related]
34. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.
Stephenson AJ; Bosl GJ; Motzer RJ; Kattan MW; Stasi J; Bajorin DF; Sheinfeld J
J Clin Oncol; 2005 Apr; 23(12):2781-8. PubMed ID: 15837993
[TBL] [Abstract][Full Text] [Related]
35. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: an update.
Yoon GH; Stein JP; Skinner DG
Urol Oncol; 2005; 23(3):168-77. PubMed ID: 15907716
[TBL] [Abstract][Full Text] [Related]
36. Late relapse in stage I of nonseminomatous germ cell testicular cancer on surveillance.
Ondrusova M; Suchansky M; Psota M; Zeleny T; Ondrus D
Bratisl Lek Listy; 2018; 119(1):3-5. PubMed ID: 29405722
[TBL] [Abstract][Full Text] [Related]
37. Secondary malignancies among nonseminomatous germ cell tumor cancer survivors.
Chamie K; Kurzrock EA; Evans CP; Litwin MS; Koppie TM; Wootton-Gorges SL; Boone JM; Lara PN; Devere White RW
Cancer; 2011 Sep; 117(18):4219-30. PubMed ID: 21412759
[TBL] [Abstract][Full Text] [Related]
38. Management of patients with non-seminomatous germ cell tumours stage I.
Rørth M; Cullen MH; Horwich A; Roth BJ
Prog Clin Biol Res; 1990; 357():295-303. PubMed ID: 2170995
[No Abstract] [Full Text] [Related]
39. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
[TBL] [Abstract][Full Text] [Related]
40. Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumour.
Masterson TA; Carver BS; Abel EJ; Pettus JA; Bosl GJ; Sheinfeld J
BJU Int; 2012 Oct; 110(7):950-5. PubMed ID: 22394608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
